NCT03673696View on ClinicalTrials.gov

The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

September 4, 2018

Primary Completion Date

July 2, 2019

Study Completion Date

July 5, 2019

Conditions
Chronic Hepatitis c
Interventions
DRUG

HEC74647PA Capsule

Capsule administered orally once daily

DRUG

placebo

Matching Placebo Capsule

Trial Locations (1)

130021

The First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY

NCT03673696 - The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter